CTLA4
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment (NCT04634058) | Shanghai Zhongshan Hospital | 2021-03-26 |
| Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors (NCT04842812) | Second Affiliated Hospital of Guangzhou Medical University | 2021-01-01 |
| Novel Genetic Disorders of the Immune System (NCT02257892) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-10-22 |
Track CTLA4 automatically
Every clearance here is in the API, with alerts when new ones post.